Showing 1 - 11 results of 11 for search 'Murray W. Huff', query time: 0.07s Refine Results
  1. 1
    Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP

    Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP by Lisa J. Wilcox, Nica M. Borradaile, Linda E. de Dreu, Murray W. Huff

    Published 2001-05-01
    Get full text
    Article
  2. 2
    Oxidized type IV hypertriglyceridemic VLDL-remnants cause greater macrophage cholesteryl ester accumulation than oxidized LDL

    Oxidized type IV hypertriglyceridemic VLDL-remnants cause greater macrophage cholesteryl ester accumulation than oxidized LDL by Stewart C. Whitman, Cynthia G. Sawyez, David B. Miller, Bernard M. Wolfe, Murray W. Huff

    Published 1998-05-01
    Get full text
    Article
  3. 3
    Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-γ

    Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-γ by Stewart C. Whitman, Carmen A. Argmann, Cynthia G. Sawyez, David B. Miller, Robert A. Hegele, Murray W. Huff

    Published 1999-06-01
    Get full text
    Article
  4. 4
    Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor*

    Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor* by Emma M. Allister, Erin E. Mulvihill, P. Hugh R. Barrett, Jane Y. Edwards, Lindsey P. Carter, Murray W. Huff

    Published 2008-10-01
    Get full text
    Article
  5. 5
    The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatins⃞

    The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatins⃞ by Dawn E. Telford, Brian G. Sutherland, Jane Y. Edwards, Joseph D. Andrews, P. Hugh R. Barrett, Murray W. Huff

    Published 2007-03-01
    Get full text
    Article
  6. 6
    Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs

    Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs by John R. Burnett, Lisa J. Wilcox, Dawn E. Telford, Sandra J. Kleinstiver, P. Hugh R. Barrett, Roger S. Newton, Murray W. Huff

    Published 1999-07-01
    Get full text
    Article
  7. 7
    Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese Ldlr−/− mice

    Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese Ldlr−/− mice by Amy C. Burke, Brian G. Sutherland, Dawn E. Telford, Marisa R. Morrow, Cynthia G. Sawyez, Jane Y. Edwards, Maria Drangova, Murray W. Huff

    Published 2018-09-01
    Get full text
    Article
  8. 8
    Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB

    Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB by Dawn E. Telford, Jane Y. Edwards, Sara M. Lipson, Brian Sutherland, P.Hugh R. Barrett, John R. Burnett, Elaine S. Krul, Bradley T. Keller, Murray W. Huff

    Published 2003-05-01
    Get full text
    Article
  9. 9
    Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr−/− mice[S]

    Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr−/− mice[S] by Julia M. Assini, Erin E. Mulvihill, Brian G. Sutherland, Dawn E. Telford, Cynthia G. Sawyez, Sarah L. Felder, Sanjiv Chhoker, Jane Y. Edwards, Robert Gros, Murray W. Huff

    Published 2013-03-01
    Get full text
    Article
  10. 10
    PPARδ activation attenuates hepatic steatosis in Ldlr−/− mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity

    PPARδ activation attenuates hepatic steatosis in Ldlr−/− mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity by Lazar A. Bojic, Dawn E. Telford, Morgan D. Fullerton, Rebecca J. Ford, Brian G. Sutherland, Jane Y. Edwards, Cynthia G. Sawyez, Robert Gros, Bruce E. Kemp, Gregory R. Steinberg, Murray W. Huff

    Published 2014-07-01
    Get full text
    Article
  11. 11
    The citrus flavonoid nobiletin confers protection from metabolic dysregulation in high-fat-fed mice independent of AMPK[S]

    The citrus flavonoid nobiletin confers protection from metabolic dysregulation in high-fat-fed mice independent of AMPK[S] by Nadya M. Morrow, Amy C. Burke, Joshua P. Samsoondar, Kyle E. Seigel, Andrew Wang, Dawn E. Telford, Brian G. Sutherland, Conor O'Dwyer, Gregory R. Steinberg, Morgan D. Fullerton, Murray W. Huff

    Published 2020-03-01
    Get full text
    Article

Search Tools: